Log in

NYSE:CHE - Chemed Stock Price, Forecast & News

$436.37
+0.87 (+0.20 %)
(As of 12/13/2019 05:49 AM ET)
Today's Range
$433.95
Now: $436.37
$438.49
50-Day Range
$394.63
MA: $418.39
$437.15
52-Week Range
$260.03
Now: $436.37
$441.79
Volume48,600 shs
Average Volume87,222 shs
Market Capitalization$6.99 billion
P/E Ratio36.58
Dividend Yield0.29%
Beta1.11
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.78 billion
Cash Flow$15.03 per share
Book Value$36.93 per share

Profitability

Net Income$205.54 million

Miscellaneous

Employees15,707
Market Cap$6.99 billion
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.


Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, November 1st. Shareholders of record on Monday, November 11th will be paid a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, November 7th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its Board of Directors has authorized a stock buyback plan on Wednesday, March 7th 2018, which authorizes the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's management believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Tuesday, October, 29th. The company reported $3.46 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.31 by $0.15. The firm earned $480.61 million during the quarter, compared to analysts' expectations of $478.89 million. Chemed had a net margin of 11.14% and a return on equity of 35.06%. The firm's quarterly revenue was up 8.2% compared to the same quarter last year. During the same period last year, the business posted $3.07 EPS. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Chemed.

What price target have analysts set for CHE?

4 equities research analysts have issued 12 month price targets for Chemed's stock. Their forecasts range from $405.00 to $500.00. On average, they anticipate Chemed's share price to reach $466.25 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price. View Analyst Price Targets for Chemed.

What is the consensus analysts' recommendation for Chemed?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Has Chemed been receiving favorable news coverage?

Press coverage about CHE stock has been trending positive this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Chemed earned a news sentiment score of 2.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Chemed.

Are investors shorting Chemed?

Chemed saw a increase in short interest in the month of November. As of November 29th, there was short interest totalling 257,700 shares, an increase of 6.5% from the November 14th total of 242,000 shares. Based on an average daily volume of 98,500 shares, the short-interest ratio is presently 2.6 days. Currently, 1.7% of the shares of the stock are sold short. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), Walt Disney (DIS), BlackRock (BLK), CVS Health (CVS), Chevron (CVX), Cisco Systems (Csco), Fortinet (FTNT), Abbott Laboratories (ABT) and Boeing (BA).

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

Who are Chemed's major shareholders?

Chemed's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (2.61%), Riverbridge Partners LLC (2.34%), Fisher Asset Management LLC (2.15%), Voya Investment Management LLC (1.17%), TimesSquare Capital Management LLC (0.97%) and Eagle Asset Management Inc. (0.81%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

Which major investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., TimesSquare Capital Management LLC, Gamco Investors INC. ET AL, Copeland Capital Management LLC, Russell Investments Group Ltd., Gabelli Funds LLC, Man Group plc and Assenagon Asset Management S.A.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

Which major investors are buying Chemed stock?

CHE stock was bought by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Carillon Tower Advisers Inc., Squarepoint Ops LLC, Teacher Retirement System of Texas, State of Tennessee Treasury Department, First Trust Advisors LP, Voya Investment Management LLC and Voloridge Investment Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $436.37.

How big of a company is Chemed?

Chemed has a market capitalization of $6.99 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

What is Chemed's official website?

The official website for Chemed is http://www.chemed.com/.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  267 (Vote Outperform)
Underperform Votes:  340 (Vote Underperform)
Total Votes:  607
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Featured Article: Commodities

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel